Integrating China in the International Consortium for Personalised Medicine (IC2PerMed) project aims to support EU-China collaboration over the developments of Personalised Medicine research, innovations, and policies through the ICPerMed initiative, providing people with access to personalised, smart and inclusive healthcare solutions in the near future [Grant Agreement N. 874694] (https://www.ic2permed.eu/).
According to the Council of the European Union, Personalised Medicine is defined as a “medical model using characterisation of individuals’ phenotypes and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention.”
You are invited to participate in a survey, elaborated within the IC2PerMed project, which aims to explore the current landscape of implementation, priorities, and challenges of Personalised Medicine in China and Europe, with a focus on Sino-European collaboration in this field.
The results of this survey will complement the ongoing mapping activities within IC2PerMed project, of which the preliminary findings can be consulted here. These results will be useful to have an overview of the past, current and future policy, research, and funding in Personalized Medicine in your country and will serve the basis for the Working Groups (WG) of the IC2PerMed project. The WGs’ activities will take advantage of the results of this survey, to support the project in developing recommendations for implementing the ICPerMed’s Action plan into China (https://www.ic2permed.eu/working-groups/).
For any further information, please contact: IC2PerMed@unicatt.it.
Thank you very much for your participation
Walter Ricciardi, on behalf of IC2PerMed the consortium
If you agree to participate in this survey according to GDPR regulation, please click Next.